L. Rubbia-Brandt

Discipline

Sciences de l'information et de la communication (1) Economies et finances (1)

Type de document

Articles (9)

Co-auteur

Date

Source

Mot-clé

Human beings (7) Patients (5) Hepatitis C (5) Cancer (5) Patients (5) Hepatitis C virus (4) Liver (4) Fatty degeneration (4) protéine (3) pathologie (3) lipide (3) effet (3) maladie (3) Treatment (3) RNA (3) Pathology (3) Expression (3) maladie (3) thérapie (2) technologie (2) épuration (2) infiltration (2) infection (2) analyse (2) investigation (2) adulte (2) Development (2) Care (2) Scores (2) Tissues (2)

Documents écrit par L. Rubbia-Brandt (9) | parle de L. Rubbia-Brandt (0)

Towards a national strategy for digital pathology in Switzerland.
A. Janowczyk et al.
Optimized low-dose combinatorial drug treatment boosts selectivity and efficacy of colorectal carcinoma treatment.
M. Zoetemelk et al.
Editorial: Tumor Heterogeneity.
S. La Rosa et al. (2019)
Advancing synoptic cancer reports beyond English: the University of Bern/PathoLink approach.
Y. Banz et al.
An in vitro model of hepatitis C virus genotype 3a-associated triglycerides accumulation.
K. Abid et al.
Lack of in vivo blockade of Fas- and TNFR1-mediated hepatocyte apoptosis by the hepatitis C virus.
L. Rubbia-Brandt et al.
The 4,977-base pair common deletion of mitochondrial DNA is not associated with steatosis in chronic hepatitis C patients.
P. Latorre et al.
Detection of the negative-strand hepatitis C virus RNA in tissues: implications for pathogenesis.
R. Quadri et al.
Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3.
L. Rubbia-Brandt et al.